Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 369.45 | 4481.00 | 6960.50 | 0.6438 | 0.8025 |
MCF 10A | 17-AAG | 0.001 | uM | 9 | 1250.00 | 369.45 | 6624.00 | 6960.50 | 0.9517 | 0.9767 |
MCF 10A | 0 | uM | 9 | 1250.00 | 369.45 | 7566.00 | 6960.50 | 1.0870 | 1.0398 | |
MCF 10A | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 369.45 | 5523.00 | 6960.50 | 0.7935 | 0.8937 |
MCF 10A | Linsitinib | 1 | uM | 9 | 1250.00 | 369.45 | 3469.00 | 6960.50 | 0.4984 | 0.6968 |
MCF 10A | 0 | uM | 9 | 1250.00 | 369.45 | 6718.00 | 6960.50 | 0.9652 | 0.9833 | |
MCF 10A | 0 | uM | 9 | 1250.00 | 369.45 | 7119.00 | 6960.50 | 1.0228 | 1.0107 | |
MCF 10A | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 369.45 | 1380.00 | 6960.50 | 0.1983 | 0.3650 |
MCF 10A | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 369.45 | 2903.00 | 6960.50 | 0.4171 | 0.6269 |
MCF 10A | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 369.45 | 6745.00 | 6960.50 | 0.9690 | 0.9852 |
MCF 10A | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 369.45 | 7090.00 | 6960.50 | 1.0186 | 1.0087 |
MCF 10A | Linsitinib | 0.1 | uM | 9 | 1250.00 | 369.45 | 6735.00 | 6960.50 | 0.9676 | 0.9845 |
MCF 10A | Lapatinib | 0.1 | uM | 9 | 1250.00 | 369.45 | 8234.00 | 6960.50 | 1.1830 | 1.0809 |
MCF 10A | 0 | uM | 9 | 1250.00 | 369.45 | 6624.00 | 6960.50 | 0.9517 | 0.9767 | |
MCF 10A | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 369.45 | 7431.00 | 6960.50 | 1.0676 | 1.0311 |
MCF 10A | 0 | uM | 9 | 1250.00 | 369.45 | 6888.00 | 6960.50 | 0.9896 | 0.9951 | |
MCF 10A | Linsitinib | 0.01 | uM | 9 | 1250.00 | 369.45 | 9121.00 | 6960.50 | 1.3104 | 1.1318 |
MCF 10A | 17-AAG | 0.1 | uM | 9 | 1250.00 | 369.45 | 245.00 | 6960.50 | 0.0352 | -0.0924 |
MCF 10A | Lapatinib | 0.01 | uM | 9 | 1250.00 | 369.45 | 6752.00 | 6960.50 | 0.9701 | 0.9857 |
MCF 10A | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 369.45 | 7535.00 | 6960.50 | 1.0825 | 1.0378 |
MCF 10A | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 369.45 | 355.00 | 6960.50 | 0.0510 | -0.0094 |
MCF 10A | Erlotinib | 0.1 | uM | 9 | 1250.00 | 369.45 | 5635.00 | 6960.50 | 0.8096 | 0.9027 |
MCF 10A | 0 | uM | 9 | 1250.00 | 369.45 | 7197.00 | 6960.50 | 1.0340 | 1.0158 | |
MCF 10A | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 369.45 | 405.00 | 6960.50 | 0.0582 | 0.0219 |
MCF 10A | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 369.45 | 8906.00 | 6960.50 | 1.2795 | 1.1198 |